These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14169967)

  • 1. STASIS THROMBI INDUCED BY BACTERIAL ENDOTOXIN.
    THOMAS DP; WESSLER S
    Circ Res; 1964 Jun; 14():486-93. PubMed ID: 14169967
    [No Abstract]   [Full Text] [Related]  

  • 2. ACTIVATION PRODUCT, FACTOR IX, SERUM THROMBOTIC ACCELERATOR ACTIVITY, AND SERUM-INDUCED THROMBOSIS.
    DEYKIN D; WESSLER S
    J Clin Invest; 1964 Feb; 43(2):160-6. PubMed ID: 14162524
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathogenesis of venous thrombosis in relation to its prevention by dextran and heparin.
    Gurewich V; Thomas DP
    J Lab Clin Med; 1965 Oct; 66(4):604-12. PubMed ID: 5843088
    [No Abstract]   [Full Text] [Related]  

  • 4. ROLES OF SURFACE FACTOR AND A PLASMA INHIBITORY ACTIVITY (ANTI-SF) DURING EXPERIMENTAL THROMBOSIS IN RABBITS.
    IATRIDIS SG; IATRIDIS PG; FERGUSON JH
    Thromb Diath Haemorrh; 1964 Dec; 12():489-504. PubMed ID: 14254706
    [No Abstract]   [Full Text] [Related]  

  • 5. THE ACTIVATION AND CONSUMPTION OF FACTOR IX.
    NOSSEL HL
    Thromb Diath Haemorrh; 1964 Dec; 12():505-9. PubMed ID: 14254707
    [No Abstract]   [Full Text] [Related]  

  • 6. ROLE OF FACTORS XII, XI, AND IX IN SERUM AND PLASMA-INDUCED THROMBOSIS.
    REIMER SM; THOMAS DP
    Am J Physiol; 1963 Dec; 205():1265-9. PubMed ID: 14084997
    [No Abstract]   [Full Text] [Related]  

  • 7. [THE PHYSIOLOGICAL INHIBITORS OF BLOOD COAGULATION IN PATHOLOGICALLY INCREASED COAGULABILITY IN VIVO. I. CONSUMPTION COAGULOPATHY IN THE SHWARTZMAN-SANARELLI PHENOMENON].
    SCHIMPF K; CIBELLIUS A
    Klin Wochenschr; 1964 May; 42():431-5. PubMed ID: 14230116
    [No Abstract]   [Full Text] [Related]  

  • 8. [INDICATIONS FOR FRESH BLOOD AND PRESERVED BLOOD IN DEFICIENCIES OF BLOOD COAGULATION FACTORS].
    SOULIER JP
    Transfusion (Paris); 1964; 7():253-6. PubMed ID: 14212678
    [No Abstract]   [Full Text] [Related]  

  • 9. The contact phase of coagulation in the presence of heparin.
    BLOOM AL
    J Clin Pathol; 1962 Nov; 15(6):508-10. PubMed ID: 13971779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and experimental studies on the contact factor. II. Experimental studies on the thrombotic activity of activation product].
    Ito M
    Nihon Ketsueki Gakkai Zasshi; 1968 Dec; 31(7):1155-64. PubMed ID: 5753796
    [No Abstract]   [Full Text] [Related]  

  • 11. [BLOOD CLOTTING FACTOR IN HEMOLYSATES].
    OGIWARA Y
    Nihon Ketsueki Gakkai Zasshi; 1963 Dec; 26():779-87. PubMed ID: 14154695
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on syndromes of disseminated intravascular coagulation, in vitro and animal studies.
    Watanabe T
    Acta Med Biol (Niigata); 1970 Jul; 18(1):49-69. PubMed ID: 5484571
    [No Abstract]   [Full Text] [Related]  

  • 13. Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins).
    Morrison DC; Cochrane CG
    J Exp Med; 1974 Sep; 140(3):797-811. PubMed ID: 4378413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgE-induced blood coagulation alterations in the rabbit: consumption of coagulation factors XII, XI, and IX in vivo.
    Pinckard RN; Tanigawa C; Halonen M
    J Immunol; 1975 Aug; 115(2):525-32. PubMed ID: 50367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OBSERVATIN OF FACTOR XII AND FACTOR XII DEFICIENT PLASMA AT AN INTERFACE.
    ADAMS AL; VROMAN L
    Thromb Diath Haemorrh; 1965 Jun; 13():387-93. PubMed ID: 14347862
    [No Abstract]   [Full Text] [Related]  

  • 16. NATURE AND ACTION OF INTERMEDIATE PRODUCT I.
    SPAET TH
    Fed Proc; 1964; 23():757-61. PubMed ID: 14195459
    [No Abstract]   [Full Text] [Related]  

  • 17. THE INDUCTION OF PERMEABILITY-INCREASING ACTIVITY IN HUMAN PLASMA BY ACTIVATED HAGEMAN FACTOR.
    RATNOFF OD; MILES AA
    Br J Exp Pathol; 1964 Jun; 45(3):328-45. PubMed ID: 14173175
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of collagen and kaolin on the intrinsic coagulant activity of platelets. Evidence for an alternative pathway in intrinsic coagulation not requiring factor XII.
    Walsh PN
    Br J Haematol; 1972 Apr; 22(4):393-405. PubMed ID: 5028124
    [No Abstract]   [Full Text] [Related]  

  • 19. Dl-ethionine-induced clotting factor deficiencies in the dog with survival.
    Molokhia FA; Ponn RB; Asimacopoulos PJ; Sise HS; Norman JC
    Surgery; 1971 May; 69(5):741-7. PubMed ID: 5575502
    [No Abstract]   [Full Text] [Related]  

  • 20. [Coagulation changes following injection of a purified contact activation product].
    Barth P; Czygan P; Zimmermann R
    Verh Dtsch Ges Inn Med; 1971; 77():1029-32. PubMed ID: 5155957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.